Trial Site Detail

 

Drug:
Cabozantinib
Trial:
Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

The Cancer Institute Hospital of the Japanese Foundation

     
Ariake , Koto 135-8550
Japan

 

Principal Investigator:
Makoto Nishio, MD
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
The Cancer Institute Hospital of the Japanese Foundation Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.